Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Maternal and fetal exposures to fluoride during mid-gestation among pregnant women in northern California

Abstract

Background

Previous studies have shown a correlation between fluoride concentrations in urine and community water fluoride concentrations. However, there are no studies of the relationship between community water fluoridation, urine, serum, and amniotic fluid fluoride concentrations in pregnant women in the US. The aim of this study was to determine the relationship between maternal urine fluoride (MUF), maternal urine fluoride adjusted for specific gravity (MUFSG), maternal serum fluoride (MSF), amniotic fluid fluoride (AFF) concentrations during pregnancy, and community water fluoridation in Northern California.

Methods

Archived samples of urine, serum and amniotic fluid collected from second trimester pregnant women in Northern California from 47 different communities in Northern California and one from Montana (n = 48), were analyzed for fluoride using an ion specific electrode following acid microdiffusion. Women’s addresses were matched to publicly reported water fluoride concentrations. We examined whether fluoride concentrations in biospecimens differed by fluoridation status of the community water, and determined the association between water fluoride concentrations and biospecimen fluoride concentrations using linear regression models adjusted for maternal age, smoking, Body Mass Index (BMI), race/ethnicity, and gestational age at sample collection.

Results

Fluoride concentrations in the community water supplies ranged from 0.02 to 1.00 mg/L. MUF, MSF , and AFF concentrations were significantly higher in pregnant women living in communities adhering to the U.S. recommended water fluoride concentration (0.7 mg/L), as compared with communities with less than 0.7 mg/L fluoride in drinking water. When adjusted for maternal age, smoking status, BMI, race/ethnicity, and gestational age at sample collection, a 0.1 mg/L increase in community water fluoride concentration was positively associated with higher concentrations of MUF (B = 0.052, 95% CI:0.019,0.085), MUFSG (B = 0.028, 95% CI: -0.006, 0.062), MSF (B = 0.001, 95% CI: 0.000, 0.003) and AFF (B = 0.001, 95% CI: 0.000, 0.002).

Conclusions

We found universal exposure to fluoride in pregnant women and to the fetus via the amniotic fluid. Fluoride concentrations in urine, serum, and amniotic fluid from women were positively correlated to public records of community water fluoridation. Community water fluoridation remains a major source of fluoride exposure for pregnant women living in Northern California.

Peer Review reports

Introduction

In the United States (US), water and water-based beverages contribute to approximately 75% of the total fluoride intake among adults living in communities that fluoridate their water supply [1]. The most recent estimates posted by the US Centers for Disease Control and Prevention (CDC), are that nearly three-fourths of the U.S. population with access to community water systems receive water adjusted to the federally recommended concentration of 0.7 mg/L fluoride (https://www.cdc.gov/fluoridation/statistics/2016stats.htm). This concentration of community water fluoridation in the US is higher than in Canada, where approximately one-third of Canadian communities fluoridate their water supply, and Europe, where only 3% of Europeans have fluoridated water [2, 3]. Recent studies of the potential effects of fluoride on neurodevelopment from prenatal exposures [4,5,6,7,8], and the onset of puberty in boys [6], suggest the need to evaluate fluoride concentrations in communities in the US and their relationship to fluoride concentrations in pregnant women.

Enamel fluorosis, which is a bioindicator for systemic fluoride exposure during times of tooth enamel formation, has been increasing in the US. In 1986–1987, 22.6% of adolescents aged 12–15 were reported to have dental fluorosis, and this increased to 40.7% in 1999–2004 [9]. In adolescents aged 16 and 17 years, fluorosis prevalence was reported to have again increased by 31.6% in 2012–2011, as compared with concentrations in 2002–2001 [10]. The purported increase in enamel fluorosis has led to concerns that overall systemic fluoride exposure is increasing, and in 2015 the CDC recommended concentrations for fluoride in drinking water be reduced from 1 mg/L fluoride to 0.7 mg/L fluoride [11]. However, the US Environmental Protection Agency has continued to allow fluoride concentrations of up to 4 mg/L in drinking water (https://www.epa.gov/ground-water-and-drinking-water/national-primary-drinking-water-regulations).

There are no contemporary measurements of systemic fluoride in adult humans in the United States, and no evaluation of their relationship to water fluoridation. Additionally, there are no contemporary studies of fluoride concentrations in pregnant women in fluoridated communities in the US, nor in fetal related tissues, despite recent concerns about effects on neurodevelopment.

To address this, we measured fluoride concentrations in urine, serum and amniotic fluid of second trimester pregnant women in Northern California. We used publicly available information on fluoride concentrations in their water systems to evaluate the relationship between reported fluoride concentrations and biomonitoring measurements, to assess the contribution of water fluoridation to measured fluoride concentrations in biological samples.

Methods

Study sample

Maternal urine, serum, and amniotic fluid were collected, and archived, between 2014 and 2016, from a total of 138 second trimester pregnant women with uncomplicated pregnancies from Northern California seeking care at Zuckerberg San Francisco General Hospital. Women stayed 1 to 2 days in San Francisco, which is fluoridated, and fasting urine samples were collected on day 2. The specific gravity of the urine samples was measured at the time of collection. Samples were labeled with a unique identification and barcode and then aliquoted into smaller Cryovials® and stored at -80 °C. Of these samples, 50 were selected from boxes whose records were easily accessible, with an equal number selected from sample collection dates in 2014, 2015, and 2016. The samples were selected from women residing in different communities across Northern California, and one residing in Montana. Two of the samples were excluded from analysis due to the unavailability of water fluoride concentrations. One sample was further excluded from amniotic fluid fluoride analysis due to sample unavailability, leaving a final study population of 48 for urine and maternal serum analysis and 47 for those with amniotic fluid. Women’s addresses were abstracted from the medical record. We were only able to obtain zip codes and not full addresses for four women.

The women were racially and ethnically diverse, with an average age of 25.7 years (Table 1). The majority had a high school education or less, and more than a third had no children at the time of sample collection (Table 1). More than two-thirds of the participants reported smoking in the past year. This study was approved by the University of California, San Francisco Committee on Human Research.

Table 1 Descriptive statistics

Fluoride measurements

Fluoride concentrations were determined using a modification of the hexamethyldisiloxane (HMDS; Sigma Chemical Co.) microdiffusion procedure of Taves [12], as modified by Martínez- Mier et al. (Martinez-Mier et al., 2011). Fluoride concentrations were determined by comparing the millivolt reading of each sample to standard curves, covering the range of the samples’ values, prepared from the data for standard solutions of diffused fluoride measured at the time the samples were analyzed. In neutral solutions, the limit of detection of the ion specific fluoride electrode is 0.02 mg/L fluoride. The precision and validity of the modified microdiffusion technique used in our analysis have been reported elsewhere (Martinez-Mier et al., 2011). Fluoride concentrations in urine were measured, and were also adjusted for specific gravity using the Levine Fahy equation: [ConcentrationSG normalized = Concentrationspecimen (SGreference – 1)/(SGspecimen – 1)] [13]. SGreference is the median SG for the cohort , with one sample that had a specific gravity of 1 excluded. Average water fluoride concentrations in the communities in which women lived at the year in which the samples were collected were obtained from the California Water Board website https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/Fluoridation.html, or from the water quality report of the individual city of residence using the participant addresses.

Statistical analyses

We evaluated the correlation between biological measures of fluoride and community fluoride concentrations using Pearson’s correlation. MSF, MUF, MUFSG, and AFF concentrations were log-transformed to make the distribution approximately normal. We used linear regression to evaluate the relationship between each of the biological measures of fluoride and concentrations of fluoride in community water. We controlled for the following potential confounders: maternal age [14, 15] smoking status [16, 17], BMI [18], gestational age at the time of sample collection, and race/ethnicity.

The regression model took the form Y = β0 + β1X1 + β2X2 + β3X3 + β4X4 + β5X5 + β6X6 + ɛ, where Y is the dependent variable (the measures of fluoride in each of the biospecimens); X1 is community water fluoride concentration, X2 is maternal age; X3 is a maternal smoking status (coded as 0 if the subject reported not smoking and 1 if the subject reported smoking in the past year); X4 is maternal BMI at the time of sample collection, X5 is reported maternal race/ethnicity, X6 is the gestational age at the time of sample collection, and ε is the individual-specific error.

We then used Welch’s t-tests to compare biological measurements of fluoride between communities with water fluoridated in accordance with US federal recommendations (= > 0.7 mg/L) and communities with less fluoridated water (< 0.7 mg/L). Three samples were associated with community water fluoride concentrations of 0.69 mg/L, and these values were rounded up and included in the group with fluoridated water adhering to federal recommendations (= > 0.7 mg/L).

To compare our results with urine fluoride concentrations of Canadian subjects [3] in communities with high and low fluoride concentrations, we reanalyzed our data using the fluoride concentrations similar to those in the Canadian study. In this study, fluoridated communities were defined as those with 0.3 mg/L or greater fluoride in water, and non-fluoridated communities had less than 0.3 mg/L fluoride in water.

All data analyses were conducted using R version 3.6.0.

Results

Participants primarily resided in communities across Northern and Central California, and fluoride concentrations recorded for the community water samples ranged from 0.02 to 1.00 mg/L (Fig. 1). One participant lived in Montana but is not shown in Fig. 1 for map clarity. Following acid diffusion, fluoride could be measured within the linear range of the fluoride electrode in all patient samples. MSF and AFF concentrations were similar to one another, but an order of magnitude lower than the concentrations observed in community water and MUF concentrations (Table 1).

Fig. 1
figure1

Map of the location of pregnant women participants and the community water fluoridation concentrations. Note: One participant lived in Montana at the time of sample collection but was excluded from this map for clarity

Mean MUF concentration, with and without adjustment for specific gravity (SG) in the communities with = > 0.7 mg/L, were similar to the mean water fluoride concentration, whereas in communities with less than 0.7 mg/L fluoride, MUF and MUFSG concentrations were higher than the mean community water fluoride concentrations (see Table 2). While there is a clear correlation between MUF and community water fluoridation, there is also much variability in the individual MUF, particularly as fluoride concentrations in the drinking water increase (Fig. 2 and Table 3).

Table 2 Concentrations of fluoride in maternal urine, serum, and amniotic fluid by community water fluoridation concentration
Fig. 2
figure2

Scatter plots of community water fluoride concentrations with fluoride concentrations in maternal urine, maternal urine adjusted for specific gravity, maternal serum, and amniotic fluid

Table 3 Correlation matrix between log-transformed fluoride concentrations in maternal urine, maternal urine adjusted for specific gravity, maternal serum, and amniotic fluid with fluoride concentrations in community water.

A 0.1 mg/L increase in the community water fluoride concentration was associated with an increase of 0.052 (95% CI: 0.019, 0.085) in MUF; and of 0.028 (95% CI: 0.006, 0.062) in MUFSG after adjusting for covariates (Table 4). The associations between community water fluoride concentrations and MSF and AFF were very similar: a 0.1 mg/L increase in community water fluoride was associated with increases of 0.001 (95% CI 0.000, 0.003) in MSF and 0.001 (95% CI 0.000, 0.002) AFF. The unadjusted associations were strongest between water fluoride and AFF (Table 3). For all biospecimens, we did not find any effect of the potential co-founders, including smoking, which in adolescents has been reported to be associated with increased plasma fluoride concentrations [19].

Table 4 Adjusted and unadjusted linear associations of 0.1 mg/L increase in community water fluoride concentrations with fluoride concentrations in maternal urine, serum, and amniotic fluid

In a previous study of community water fluoride concentrations and associated MUFSG in Canada, [3], fluoridated communities had fluoride concentrations greater than 0.3 mg/L fluoride in drinking water, and non-fluoridated communities had 0.3 mg/L fluoride or less in drinking water. To compare our results with those found in the Canadian study, we compared MUFSG concentrations of pregnant women across communities with less than or greater than 0.3 mg/L fluoride in drinking water. We found the mean urine fluoride concentrations were similar in our Northern California sample to those in Canada (Table 5).

Table 5 Comparison of fluoride concentrations in mg/L across communities with low and high fluoridation concentrations in Northern California and Canada

Discussion

We measured fluoride concentrations in urine, serum, and amniotic fluid from 47 second trimester pregnant women primarily living in Northern California between 2014 and 2016. To our knowledge, this is the first time these types of data have been reported in the US. In our study, which used archived biological samples, community water fluoride samples from the time of collection were not available. Therefore, we used public records to determine the water fluoride concentrations for each community in the year that the samples were collected.

Fluoride measurements using a fluoride ion specific electrode are highly specific when the sample is buffered to a pH below 7 to prevent the interference of hydroxyl ions. However, fluoride concentrations in serum or plasma are close to the limit of detection (LOD) of the electrode of 0.02 mg/L (mg/L) and therefore the hexamethyldisiloxane (HMDS) facilitated diffusion method, originally derived by Taves [12], and further modified by Martinez-Mier et al., (Martinez-Mier et al., 2011) quantitatively transfers fluoride from the sample into an alkaline trapping solution of smaller volume. This process results in fluoride concentrations in the solution that are above the LOD and on the linear portion of the standard curve. Furthermore, this method is preferred for samples that contain protein as it also releases additional fluoride ions that may be bound to proteins through binding to cations or other positively charged molecular groups.

Urine from healthy individuals, which has a relatively low protein content, can be measured directly, without diffusion. However, because we did not know the medical history of our sample population, we used the diffusion method to measure the fluoride concentration in urine, as well in serum and amniotic fluid. Urine fluoride concentrations were measured in spot samples rather than 24-hour urine samples. Urine spot samples have been shown to be an accurate assessment of fluoride ingestion on a population basis [20]. We found similar MUFSG concentrations for pregnant women in Northern California relative to their community water fluoride concentrations, as reported by Till et al. in a Canadian population [3]. Community water fluoride concentration and MUFSG were associated in both this study, and the study by Till et al., although in this study the confidence intervals for both the adjusted and unadjusted associations crossed the null.

The formula used to correct for specific gravity was originally generated in 1945 by Levine and Jahy [13], to adjust for urinary lead concentrations. However, this formula has recently been questioned; in particular, there are concerns about whether it overcompensates for the confounding effect of specific gravity in the absence of an appropriately weighted exponential adjustment factor for the substance of interest [13, 21, 22]. There is no such factor yet defined for fluoride; therefore, we also present associations with maternal urine unadjusted for specific gravity (Table 2). We found that unadjusted maternal urine fluoride was significantly positively associated with water fluoride concentrations.

The similarity in urine fluoride measures in Till’s study of a larger cohort of Canadian women [3] and ours, supports the validity of our relatively small sample size, and underlines the usefulness of MUF as a biomarker to compare study outcomes relative to fluoride intake. However, we did not have access to information on additional possible fluoride exposure through dental products, or the use of tea, bottled drinks or water; which is a limitation to this study. With the inclusion of this data, we may have identified more differences between our US derived samples and those from the Canadian study.

Similarly to the findings by Smith et al. [23] and Zipkin et al. [20] in the US in the 1950s, we found that the mean concentration of fluoride in urine of women from fluoridated communities (MUF) was similar (0.74 mg/L) to mean concentrations of fluoride in drinking water (0.8 mg/L) (see Table 2). However, in our study, mean urine fluoride concentrations from communities with lower water fluoride concentrations (0.52 mg/L) were more than twice that of community water fluoride concentrations (0.2 mg/L). It is possible that the relative increase in urine fluoride concentrations of women from non-fluoridated communities, was due to the overnight stay in fluoridated San Francisco. However, these values for non-fluoridated communities were similar to those reported by Till et al. [3], suggesting that in both Canada and the US, there is increased exposure to other sources of fluoride outside of the community water supply. For example, consumption of bottled drinks made in areas with higher fluoride concentrations, which are then consumed in the lower fluoride areas, may increase fluoride exposure. This so-called “halo” effect of fluoride exposure [24, 25] would not have been present in previous times when most community water, including that used for the manufacturing of food and beverages, was at concentrations less than 1.0 mg/L fluoride.

Smith et al. previously reported that the fold increase of urine fluoride as compared to blood fluoride concentration (4.3 fold), was lower in communities with low fluoride in drinking water as compared to communities with higher water fluoride (28 fold) [23]. This reported difference between lower and higher fluoride exposure suggests an increase in glomerular filtration rate with increasing fluoride exposure. However, Malin et al. [26] showed evidence of reduced glomerular filtration rates associated with increased water fluoride, which would result in a decrease, rather than an increase in the fold difference between urine and blood fluoride [27]. Instead, the relatively high blood fluoride concentrations as compared to urine fluoride in the low fluoride group reported by Smith et al., may have been due to sampling techniques as suggested by Taves [28], or more likely, because they had reached the limits of detection in their method for measuring low concentrations of fluoride in blood. Our results show a consistent and significant association between water fluoride, urine fluoride and serum fluoride, and support the use of urine fluoride as a biomarker for systemic fluoride exposure.

We found fluoride concentrations in amniotic fluid to be similar to maternal serum fluoride concentrations, and both were positively correlated to community water fluoride concentrations. These concentrations of amniotic fluid fluoride are similar to those reported by Ron et al. [29] drawn during mid trimester amniocentesis. However, in that study, maternal plasma concentrations were higher than what we measured for maternal serum. Fluoride concentrations in plasma and serum are comparable, and therefore a possible reason for the differences between ours and Ron’s study, may be related to their use of direct fluoride measurements, without prior diffusion, which would therefore be at the limits of fluoride detection by the electrode.

Our finding of similar fluoride concentrations between maternal serum and amniotic fluid supports direct diffusion of fluoride from maternal serum, without a placental barrier. This is supported by data from Amstrong [30] who found that ashed sera from maternal and umbilical blood obtained after cesarean section, contained similar concentrations of fluoride. Shen and Taves subsequently measured fluoride in maternal and cord blood at birth in 5 subjects using the fluoride diffusion method and found the concentration of fluoride in cord blood to be approximately 75% of maternal serum. They concluded that the high positive correlation between maternal and cord blood (0.86) showed that fluoride passively diffuses across the placenta [31]. It is likely that the difference between these studies may have been related to the time of sampling, as circulating fetal fluoride concentrations are reduced later in gestation as fluoride is taken up into the rapidly growing skeleton. Though Gedalia is frequently quoted as providing evidence that the placenta creates a barrier to fluoride [32] he reversed this in a later publication [33] confirming the free passage of fluoride between mother and fetus. The difference in his findings over time has been attributed to methodological differences in his fluoride analysis.

Gupta et al. reported that when maternal plasma fluoride concentrations were greater than 0.4 mg/L, that fetal cord blood fluoride concentrations were relatively reduced [34]. This finding has been interpreted as evidence that a placental barrier occurs at high fluoride concentrations. However, 0.4 mg/L is an extremely high plasma fluoride concentration, and is over 10 fold the highest maternal serum concentration measured in our study. Reports of these high plasma fluoride concentrations suggest the possibility that there were measurement errors. If they are correct, then is likely that other systemic toxic effects that would occur at these concentrations [35], would account for the differences in fluoride concentrations, rather than a specific placental barrier to fluoride ion diffusion.

The early formed amniotic fluid is formed by diffusion of maternal plasma through the placenta, and is replaced by fetal urine at about 20 weeks. This early formed amniotic fluid is contained in the neural tube when it closes at approximately the 4th week of pregnancy, [36], and forms the nascent cerebrospinal fluid (CSF) [37], where it interacts with the developing brain. The importance of this early cerebral spinal fluid in brain development is demonstrated in Xenopus embryos, where exposure to a mixture of ubiquitous chemicals at concentrations found in human amniotic fluid affect thyroid hormone-dependent transcription, gene expression, brain development and behaviour in early embryogenesis [38]. While our analyses were done on midtrimester amniotic fluid, given recent population based correlations between systemic fluoride exposure and neurotoxicity [8], further studies of how fluoride may also affect early brain development in concert with other environmental stressors, are warranted.

Conclusions

This study adds evidence in support of the use of urinary fluoride as a biomarker for systemic fluoride exposure in pregnant women. However, as the association between maternal serum fluoride and water fluoride was highly significant, maternal serum maybe the best proxy for fetal exposure in studies of the impact of fluoride exposure on fetal and infant development. When maternal serum fluoride is not available, then urine fluoride is also a good proxy for fetal exposure.

Availability of data and materials

The datasets generated during and/or analysed during the current study are not publicly available due to patient privacy protections but are available from the corresponding author on reasonable request.

Abbreviations

AFF:

Amniotic fluid fluoride

BMI:

Body mass index

CDC:

Centers for Disease Control and Prevention

CSF:

Cerebrospinal fluid

HMDS:

Hexamethyldisiloxane

IQ:

Intelligence quotient

LOD:

Limit of detection

MSF:

Maternal serum fluoride MUFSG maternal urinary fluoride corrected for specific gravity

MUF:

Maternal urinary fluoride

SG:

Specific gravity

US:

United States

References

  1. 1.

    U.S. EPA. Fluoride: relative source contribution analysis: US Environmental Protection Agency; 2010. 820-R-10-015. https://www.epa.gov/sites/production/files/2019-03/documents/fluoride-exposure-relative-report.pdf..

  2. 2.

    Canada PHAo: The State of Community Water Fluoridation across Canada. In.; 2017.

  3. 3.

    Till C, Green R, Grundy JG, Hornung R, Neufeld R, Martinez-Mier EA, Ayotte P, Muckle G, Lanphear B. Community water fluoridation and urinary fluoride concentrations in a National Sample of pregnant women in Canada. Environ Health Perspect. 2018;126(10):107001.

  4. 4.

    Bashash M, Marchand M, Hu H, Till C, Martinez-Mier EA, Sanchez BN, Basu N, Peterson KE, Green R, Schnaas L, et al. Prenatal fluoride exposure and attention deficit hyperactivity disorder (ADHD) symptoms in children at 6-12years of age in Mexico City. Environ Int. 2018;121(Pt 1):658–66.

  5. 5.

    Bashash M, Thomas D, Hu H, Martinez-Mier EA, Sanchez BN, Basu N, Peterson KE, Ettinger AS, Wright R, Zhang Z, et al. Prenatal fluoride exposure and cognitive outcomes in children at 4 and 6-12 years of age in Mexico. Environ Health Perspect. 2017;125(9):097017.

  6. 6.

    Liu Y, Tellez-Rojo M, Hu H, Sanchez BN, Martinez-Mier EA, Basu N, Mercado-Garcia A, Solano-Gonzalez M, Peterson KE. Fluoride exposure and pubertal development in children living in Mexico City. Environ Health. 2019;18(1):26.

  7. 7.

    Ding Y. YanhuiGao, sun H, Han H, Wang W, Ji X, Liu X, sun D: the relationships between low levels of urine fluoride on children's intelligence, dental fluorosis in endemic fluorosis areas in Hulunbuir, Inner Mongolia, China. J Hazard Mater. 2011;186(2–3):1942–6.

  8. 8.

    Green R, Lanphear B, Hornung R, Flora D, Martinez-Mier EA, Neufeld R, Ayotte P, Muckle G, Till C. Association between maternal fluoride exposure during pregnancy and IQ scores in offspring in Canada. JAMA Pediatr. 2019;173:940.

  9. 9.

    Beltran-Aguilar ED, Barker L, Dye BA. Prevalence and severity of dental fluorosis in the United States, 1999-2004. NCHS Data Brief. 2010;(53):1–8.

  10. 10.

    Wiener RC, Shen C, Findley P, Tan X, Sambamoorthi U. Dental fluorosis over time: a comparison of National Health and nutrition examination survey data from 2001-2002 and 2011-2012. J Dent Hyg. 2018;92(1):23–9.

  11. 11.

    Health USDo. Human Services Federal Panel on Community Water F: U.S. Public Health Service Recommendation for Fluoride Concentration in Drinking Water for the Prevention of Dental Caries. Public Health Rep (Washington, DC : 1974). 2015;130(4):318–31.

  12. 12.

    Taves DR. Determination of submicromolar concentrations of fluoride in biological samples. Talanta. 1968;15(10):1015–23.

  13. 13.

    Cone EJ, Caplan YH, Moser F, Robert T, Shelby MK, Black DL. Normalization of urinary drug concentrations with specific gravity and creatinine. J Anal Toxicol. 2009;33(1):1–7.

  14. 14.

    Husdan H, Vogl R, Oreopoulos D, Gryfe C, Rapoport A. Serum ionic fluoride: normal range and relationship to age and sex. Clin Chem. 1976;22(11):1884–8.

  15. 15.

    Torra M, Rodamilans M, Corbella J. Serum and urine ionic fluoride: normal range in a nonexposed population. Biol Trace Elem Res. 1998;63(1):67–71.

  16. 16.

    Yadav AK, Kaushik CP, Haritash AK, Singh B, Raghuvanshi SP, Kansal A. Determination of exposure and probable ingestion of fluoride through tea, toothpaste, tobacco and pan masala. J Hazard Mater. 2007;142(1–2):77–80.

  17. 17.

    Going RE, Hsu SC, Pollack RL, Haugh LD. Sugar and fluoride content of various forms of tobacco. J Am Dent Assoc. 1980;100(1):27–33.

  18. 18.

    Del Carmen AF, Javier FH, Aline CC. Dental fluorosis, fluoride in urine, and nutritional status in adolescent students living in the rural areas of Guanajuato, Mexico. J Int Soc Prev Community Dent. 2016;6(6):517–22.

  19. 19.

    Jain RB. Observed differentials in the levels of selected environmental contaminants among Mexican and other Hispanic American children, adolescents, adults, and senior citizens. Environ Sci Pollut Res Int. 2018;25(5):4524–43.

  20. 20.

    Zipkin I, Likins RC, McClure FJ, Steere AC. Urinary fluoride levels associated with use of fluoridated waters. Public Health Rep. 1956;71(8):767–72.

  21. 21.

    Sorahan T, Pang D, Esmen N, Sadhra S. Urinary concentrations of toxic substances: an assessment of alternative approaches to adjusting for specific gravity. J Occup Environ Hyg. 2008;5(11):721–3.

  22. 22.

    Vij HS, Howell S. Improving the specific gravity adjustment method for assessing urinary concentrations of toxic substances. Am Ind Hyg Assoc J. 1998;59(6):375–80.

  23. 23.

    Smith FA, Gardner DE, Hodge HC. Investigations on the metabolism of fluoride. II. Fluoride content of blood and urine as a function of the fluorine in drinking water. J Dent Res. 1950;29(5):596–600.

  24. 24.

    Lewis DW, Banting DW. Water fluoridation: current effectiveness and dental fluorosis. Community Dent Oral Epidemiol. 1994;22(3):153–8.

  25. 25.

    Whitford GM. Intake and metabolism of fluoride. Adv Dent Res. 1994;8(1):5–14.

  26. 26.

    Malin AJ, Lesseur C, Busgang SA, Curtin P, Wright RO, Sanders AP. Fluoride exposure and kidney and liver function among adolescents in the United States: NHANES, 2013-2016. Environ Int. 2019;132:105012.

  27. 27.

    Spak CJ, Berg U, Ekstrand J. Renal clearance of fluoride in children and adolescents. Pediatrics. 1985;75(3):575–9.

  28. 28.

    Taves DR. Normal human serum fluoride concentrations. Nature. 1966;211(5045):192–3.

  29. 29.

    Ron M, Singer L, Menczel J, Kidroni G. Fluoride concentration in amniotic fluid and fetal cord and maternal plasma. Eur J Obstet Gynecol Reprod Biol. 1986;21(4):213–8.

  30. 30.

    Armstrong WD, Singer L, Makowski EL. Placental transfer of fluoride and calcium. Am J Obstet Gynecol. 1970;107(3):432–4.

  31. 31.

    Shen YW, Taves DR. Fluoride concentrations in the human placenta and maternal and cord blood. Am J Obstet Gynecol. 1974;119(2):205–7.

  32. 32.

    Gedalia I, Brzezinski A, Zukerman H, Mayersdorf A. Placental transfer of fluoride in the human fetus at low and high F-intake. J Dent Res. 1964;43:669–71.

  33. 33.

    Gedalia I, Shapira L. Effect of prenatal and postnatal fluoride on the human deciduous dentition. A literature review. Adv Dent Res. 1989;3(2):168–76.

  34. 34.

    Gupta S, Seth AK, Gupta A, Gavane AG. Transplacental passage of fluorides. J Pediatr. 1993;123(1):139–41.

  35. 35.

    Gessner BD, Beller M, Middaugh JP, Whitford GM. Acute fluoride poisoning from a public water system. N Engl J Med. 1994;330(2):95–9.

  36. 36.

    Wilde JJ, Petersen JR, Niswander L. Genetic, epigenetic, and environmental contributions to neural tube closure. Annu Rev Genet. 2014;48(1):583–611.

  37. 37.

    Chau KF, Springel MW, Broadbelt KG, Park HY, Topal S, Lun MP, Mullan H, Maynard T, Steen H, LaMantia AS, et al. Progressive differentiation and instructive capacities of amniotic fluid and cerebrospinal fluid proteomes following neural tube closure. Dev Cell. 2015;35(6):789–802.

  38. 38.

    Fini JB, Mughal BB, Le Mevel S, Leemans M, Lettmann M, Spirhanzlova P, Affaticati P, Jenett A, Demeneix BA. Human amniotic fluid contaminants alter thyroid hormone signalling and early brain development in Xenopus embryos. Sci Rep. 2017;7:43786.

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by NIH P01ES022841, US EPA RD 83543301, and the Center for Children’s Oral Health Research (UCSF).

Author information

Affiliations

Authors

Contributions

DAU compiled data on community water fluoridation, completed data analyses and contributed to the writing of the manuscript. DEG completed data analyses and contributed to the writing of the manuscript. EAM oversaw fluoride analyses. TJW directed sample collection and contributed to the writing of the manuscript. PKD coordinated the study and contributed to the writing of the manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Pamela K. DenBesten.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the University of California, San Francisco Committee on Human Research.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abduweli Uyghurturk, D., Goin, D.E., Martinez-Mier, E.A. et al. Maternal and fetal exposures to fluoride during mid-gestation among pregnant women in northern California. Environ Health 19, 38 (2020). https://doi.org/10.1186/s12940-020-00581-2

Download citation

Keywords

  • Fluoride
  • Water
  • Pregnancy

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.